Hui-Jen Ma

发表

Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.

Z. Ren, Lan Zhang, Xiaoying Xie, 2017, Molecular and clinical oncology.

Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study

Z. Ren, Lan Zhang, Xiaoying Xie, 2019, BioMed research international.

Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching

S. Ye, Z. Ren, Bo-Heng Zhang, 2015, Journal of gastroenterology and hepatology.

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation

Z. Ren, Lan Zhang, Xiaoying Xie, 2021, Gastroenterology research and practice.

Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma

M. Chou, Shun-Fa Yang, Yi‐Chen Chen, 2009, Clinical chemistry and laboratory medicine.

Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment

D. Gao, Z. Ren, Yinying Dong, 2017, Cancer science.

γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma

S. Ye, Z. Ren, Lan Zhang, 2014, Annals of Surgical Oncology.

Disrupted BRCA1‐PALB2 interaction induces tumor immunosuppression and T‐lymphocyte infiltration in HCC through cGAS‐STING pathway

Zhiyuan Shen, B. Xia, T. K. Foo, 2022, Hepatology.

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia

Haojie Lu, Z. Ren, Lan Zhang, 2018, Communications Biology.

LncZEB1-AS1 regulates hepatocellular carcinoma bone metastasis via regulation of the miR-302b-EGFR-PI3K-AKT axis

Yao Wang, Hui-fen Li, Zhenghui Ma, 2020, Journal of Cancer.

Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma.

Z. Ren, Lan Zhang, Weizhong Wu, 2015, American journal of cancer research.

Original Article Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma

Z. Ren, Lan Zhang, Wei-Zhong Wu, 2015 .

Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15

S. Ye, D. Gao, Z. Ren, 2018, Cancer medicine.

Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia

Z. Ren, Lan Zhang, Xiaoying Xie, 2018, Communications Biology.